IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
This Quarter Return
-30.69%
1 Year Return
+48.5%
3 Year Return
-59.65%
5 Year Return
-75.84%
10 Year Return
AUM
$380M
AUM Growth
+$380M
Cap. Flow
-$128M
Cap. Flow %
-33.78%
Top 10 Hldgs %
99.94%
Holding
13
New
Increased
Reduced
5
Closed
1

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 61.94%
2 Technology 24.04%
3 Consumer Discretionary 14.01%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$74.2M
$180M 47.32%
5,469,911
-1,000,000
-15% -$32.9M
AI icon
2
C3.ai
AI
$2.33B
$91.4M 24.04%
1,386,774
-346,693
-20% -$22.9M
REAL icon
3
The RealReal
REAL
$879M
$53.3M 14.01%
2,354,080
-1,500,000
-39% -$33.9M
GKOS icon
4
Glaukos
GKOS
$5.5B
$29.1M 7.65%
346,364
-300,000
-46% -$25.2M
AGTC
5
DELISTED
Applied Genetic Technologies Corporation
AGTC
$7.12M 1.87%
1,404,515
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$6.77M 1.78%
764,918
STIM icon
7
Neuronetics
STIM
$220M
$6.15M 1.62%
497,158
-497,157
-50% -$6.15M
CDTX icon
8
Cidara Therapeutics
CDTX
$1.66B
$3.61M 0.95%
1,356,813
VERO icon
9
Venus Concept
VERO
$4.11M
$1.55M 0.41%
658,657
HIND
10
Vyome Holdings, Inc. Common Stock
HIND
$243M
$1.07M 0.28%
380,224
XENE icon
11
Xenon Pharmaceuticals
XENE
$2.98B
$148K 0.04%
8,293
DARE icon
12
Dare Bioscience
DARE
$27.2M
$85K 0.02%
50,368
KALV icon
13
KalVista Pharmaceuticals
KALV
$678M
-388,766
Closed -$7.38M